Blood-brain barrier dysfunction in acute arterial hypertension after papaverine-induced vasodilatation.
D000418:Albumins / Q000378:metabolism; D000818:Animals; D000983:Antipyrine / Q000378:metabolism; D001391:Azo Compounds; D001812:Blood-Brain Barrier; D001921:Brain / Q000473:pathology; D002199:Capillary Permeability / Q000187:drug effects; D002415:Cats; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004396:Coloring Agents; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D007457:Iodine Radioisotopes; D008680:Metaraminol; D008856:Microscopy, Fluorescence; D010208:Papaverine; D013451:Sulfonic Acids
D000418:Albumins; D001391:Azo Compounds; D004396:Coloring Agents; D007457:Iodine Radioisotopes; D013451:Sulfonic Acids; D008680:Metaraminol; D010208:Papaverine; D000983:Antipyrine